TP53 is a tumour suppressor gene located on the short arm of chromosome 17 dilution of 1 in 50 or to the dilution buffer for 30 minutes (negative control). They were then sequentially incubated for 40 minutes with peroxidase labelled species specific immunoglobulin antibodies. Peroxidaselabelled rabbit anti-mouse immunoglobulin (Dakopatts N°p161) and swine anti-rabbit immunoglobulin (Dakopatts N°p217) were diluted 1 in 20 in TBS. Visualisation was with diaminobenzidine (0-6 mglml) in the presence of 0 03% hydrogen peroxide. Endogenous peroxidase was not inhibited.
Haematoxylin was used to counterstain lightly nuclei. The inclusion in each run of HT29 cells (a human colonic carcinoma cell line known to express a high level of p53)19 was used as a positive control.
Results of immunohistochemistry were reported as either positive or negative, and compared with the histological features observed in the following frozen sections stained with haematoxylin and eosin and in the corresponding paraffin wax embedded blocks.
Results
Eight of the 11 adenocarcinomas stained positively with the human p53 specific mono- This study adds further data confirming that mutation of the p53 gene, as indicated by the abnormal expression of p53 protein defined immunohistochemically, is frequently involved in Barrett's adenocarcinoma. A prognostic value for this mutation seems unlikely, and in our study this mutation appeared as a relatively late event in the multistep process in which the characteristic epithelium in Barrett's syndrome progresses to dysplasia and eventually to adenocarcinoma.
